Abstract
In the global outbreak of coronavirus disease 2019 (COVID-19), new digital solutions have been developed for infection control. In particular, contact tracing mobile applications provide a means for governments to manage both health and economic concerns. As public reception is paramount to success, we conducted a systematic examination of sociodemographic characteristics that predict downloads of a contact tracing application. Participants were 505 adults who completed a web-based survey in Singapore, the site of the first contact tracing application (TraceTogether). We found that persons who had already changed their lifestyles on account of the pandemic were more likely to download the application. Network analyses revealed that contact tracing downloads was associated with using hand sanitizers, avoiding public transport, and preferring outdoor over indoor venues during the pandemic. However, demographic and situational characteristics were not significant predictors of application downloads. Together, these findings provide a base for policy makers to promote the uptake of digital contact tracing.
Highlights
Worldwide, digital contact tracing has been introduced to control the spread of coronavirus disease 2019 (COVID-19).
In a survey of 505 participants, we investigated sociodemographic factors predicting voluntary downloads of a contact tracing mobile application.
Use of the contact tracing application was predicted by the extent to which an individual had modified his / her behaviors because of the outbreak.
Network analyses revealed that application usage was associated with using hand sanitizers, avoiding public transport, and preferring outdoor over indoor venues.
No demographic factor significantly predicted application usage.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04468581
Funding Statement
This research was funded by a grant awarded to JCJL from the JY Pillay Global Asia Programme (grant number: IG20-SG002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yale-NUS College Ethics Review Committee (#2020-CERC-001)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author (JCJL). The data are not publicly available due to IRB restrictions.
